Showing results (121-130 of 148) with videos related to

Sort By:
Pageof 15
Microorganisms|December 24, 2021
Immune Response to BNT162b2 in Solid Organ Transplant Recipients: Negative Impact of Mycophenolate and High Responsiveness of SARS-CoV-2 Recovered Subjects against Delta VariantIrene Cassaniti, Federica Bergami, Francesca Arena, et al.
Nature Microbiology|August 31, 2016
Platelet-derived growth factor-α receptor is the cellular receptor for human cytomegalovirus gHgLgO trimerAnna Kabanova, Jessica Marcandalli, Tongqing Zhou, et al.
Journal of Medical Virology|May 6, 2025
Human Cytomegalovirus Virion-Associated mRNA as a Marker of Productive Infection in Immunocompromised PatientsFederica Giardina, Stefania Paolucci, Dalila Mele, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 28, 2021
Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational studyIrene Cassaniti, Federica Bergami, Elena Percivalle, et al.
Disease Markers|March 4, 2022
Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive ProteinManuela Rizzi, Martina Costanzo, Stelvio Tonello, et al.
The Lancet Regional Health. Europe|July 25, 2024
Corrigendum to "Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI)" [The Lancet Regional Health - Europe 40 (2024) 100892]Marianne Leruez-Ville, Christos Chatzakis, Daniele Lilleri, et al.
Frontiers in Immunology|August 7, 2023
SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohortManuela Rizzi, Stelvio Tonello, Cristiana Brinno, et al.
Disease Markers|May 9, 2022
Baseline Plasma Gas6 Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 PatientsStelvio Tonello, Manuela Rizzi, Erica Matino, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 24, 2022
Characteristics and outcomes of vaccinated and nonvaccinated patients hospitalized in a single Italian hub for COVID-19 during the Delta and Omicron waves in Northern ItalyFrancesca Rovida, Giuliana Lucia Esposito, Marco Rissone, et al.
The Lancet Regional Health. Europe|April 9, 2024
Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI)Marianne Leruez-Ville, Christos Chatzakis, Daniele Lilleri, et al.
Pageof 15